Market Overview The global neuropathic pain market is experiencing significant growth, driven by the increasing prevalence of chronic conditions such as diabetes, cancer, and neurological disorders. In 2023, the market was valued at approximately USD 7.81 billion and is projected to reach USD 14.10 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.81% during the...